198 related articles for article (PubMed ID: 31043325)
1. Prophylactic postnatal corticosteroids: Early hydrocortisone.
Baud O; Watterberg KL
Semin Fetal Neonatal Med; 2019 Jun; 24(3):202-206. PubMed ID: 31043325
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
Watterberg KL; Gerdes JS; Cole CH; Aucott SW; Thilo EH; Mammel MC; Couser RJ; Garland JS; Rozycki HJ; Leach CL; Backstrom C; Shaffer ML
Pediatrics; 2004 Dec; 114(6):1649-57. PubMed ID: 15574629
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
Morris IP; Goel N; Chakraborty M
Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162
[TBL] [Abstract][Full Text] [Related]
4. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(2):111-7. PubMed ID: 20150750
[TBL] [Abstract][Full Text] [Related]
5. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis.
Shaffer ML; Baud O; Lacaze-Masmonteil T; Peltoniemi OM; Bonsante F; Watterberg KL
J Pediatr; 2019 Apr; 207():136-142.e5. PubMed ID: 30416014
[TBL] [Abstract][Full Text] [Related]
6. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.
Peltoniemi O; Kari MA; Heinonen K; Saarela T; Nikolajev K; Andersson S; Voutilainen R; Hallman M
J Pediatr; 2005 May; 146(5):632-7. PubMed ID: 15870666
[TBL] [Abstract][Full Text] [Related]
8. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
9. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
[TBL] [Abstract][Full Text] [Related]
10. Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Héneau A; Guimiot F; Mohamed D; Rideau Batista Novais A; Alberti C; Baud O;
Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29348196
[TBL] [Abstract][Full Text] [Related]
11. Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia.
Htun ZT; Schulz EV; Desai RK; Marasch JL; McPherson CC; Mastrandrea LD; Jobe AH; Ryan RM
J Perinatol; 2021 Aug; 41(8):1783-1796. PubMed ID: 34012057
[TBL] [Abstract][Full Text] [Related]
12. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
[TBL] [Abstract][Full Text] [Related]
13. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
[TBL] [Abstract][Full Text] [Related]
14. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
15. Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.
Jensen EA; Laughon MM; DeMauro SB; Cotten CM; Do B; Carlo WA; Watterberg KL
Semin Perinatol; 2022 Nov; 46(7):151638. PubMed ID: 36085059
[TBL] [Abstract][Full Text] [Related]
16. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
17. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Renolleau C; Toumazi A; Bourmaud A; Benoist JF; Chevenne D; Mohamed D; Alberti C; Biran V; Baud O;
J Pediatr; 2021 Jul; 234():65-70.e3. PubMed ID: 33359303
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia.
Romijn M; Onland W; van Keulen BJ; Heijboer AC; Rotteveel J; van Kaam AH; Finken MJJ
Pediatr Res; 2023 Nov; 94(5):1804-1809. PubMed ID: 37355738
[TBL] [Abstract][Full Text] [Related]
19. Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Jensen EA; Dysart KC; Gantz MG; Carper B; Higgins RD; Keszler M; Laughon MM; Poindexter BB; Stoll BJ; Walsh MC; Schmidt B;
J Pediatr; 2017 Jul; 186():34-40.e2. PubMed ID: 28258737
[TBL] [Abstract][Full Text] [Related]
20. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
